Arcus Biosciences RCUS 深 滬
交易中 09-20 12:35:53 美东时间
16.71
-0.090
-0.54%
華盛通- 最 高17.03
- 今 開16.95
- 成交量 18.12万股
- 最 低 16.615
- 昨 收 16.80
- 總市值 12.45亿
- 52周最高 20.31
- 市盈率 靜 --
- 換手率 0.24%
- 52周最低 12.95
- 委 比 -75.46%
- 總股本 7450.37万
- 歷史最高 49.10
- 量 比 0.75
- 振 幅 2.47%
- 歷史最低 6.30
- 每 手 1
- 風險率 1.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Hold Rating on Arcus Biosciences Amid TIGIT Inhibitor Uncertainties
Bank of America Securities analyst Jason Zemansky maintained a Hold rating on A...
09-16 18:55
Arcus up 4% following Merck Welireg kidney cancer data
Shares of Arcus Biosciences (NYSE:RCUS) are up 4% in Friday afternoon trading after Merck (MRK) data on its drug Welireg (belzutifan) in a type of kidney cancer presented at a medical conference appea...
09-14 03:36
快讯 | arcus biosciences：设施增加了操作灵活性，为最近宣布的Casdatifan第3阶段Peak-1研究提供资金。
Arcus Biosciences: Facility Adds Operational Flexibility & Provides Funding...
08-28 04:20
Arcus Biosciences secures $250M term loan facility
Arcus Biosciences (NYSE:RCUS) reported it has obtained a $250M term loan facility from Hercules Capital. The additional capital strengthens Arcus’s balance sheet and increases flexibility to rapidly a...
08-28 04:18
快讯 | arcus biosciences从海格投资获得了高达2500万美元的贷款设施
Arcus Biosciences Secures up to $250 Million Term Loan Facility From Hercules C...
08-28 04:05
快讯 | Arcus Biosciences股份有限公司: Leerink Partners将目标价从35美元上调至46美元
Arcus Biosciences Inc : Leerink Partners Raises Target Price to $46 From $35
08-19 18:33
Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
During the last three months, 4 analysts shared their evaluations of Arcus Bios...
08-10 00:00
Arcus Biosciences Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-09 21:30
快讯 | Arcus Biosciences公司：美银全球研究将价格目标从24美元下调至23美元
Arcus Biosciences Inc : BofA Global Research Cuts Price Objective to $23 From $...
08-09 18:59
